Abstract Details

Title New Onset Atrial Fibrillation. Changing the Pathophysiological Paradigm: Neurogenic Origin in Younger Patients with a Healthy Heart?

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 026

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
	No disclosure on file
Esther Cubo Delgado, MD, PhD, FAAN (Fundacion Burgos Investigacion Salud CIF G09254616)	Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.

��ɫ��